This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ASHTON L. WELSH, M.S., M.D.

AMA Arch Derm Syphilol. 1954;69(4):418-427.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

IN AUGUST, 1952, an editorial in The Journal of the American Medical Association was devoted to a new long-acting estrogen, TACE. Because of its importance, major portions of the editorial are quoted herewith.

The discovery that the synthetic compound diethylstilbestrol possessed high estrogenic activity when administered orally prompted a search for related compounds with a more prolonged activity. In 1942, Robson and his associates reported that the triphenyl ethylene derivative diethoxy-triphenyl bromoethylene (-di[-p-ethoxyphenyl] β-phenyl bromoethylene), or D. B. E., showed a markedly prolonged estrogenic action in mice subjected to ovariectomy when given in doses somewhat greater than those producing a threshold response. The English investigators showed this prolonged effect was due to the fact that, on introduction into the body, D. B. E. in contrast to the estrogenic substances then available was not immediately destroyed or excreted in the urine but was stored in a number of . . . [Full Text PDF of this Article]

Author Affiliations
CINCINNATI

Footnotes
TACE is the trademark of the Wm. S. Merrell Company, Cincinnati, for its brand of chlorotrianisene (tri-p-anisylchloroethylene).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?